/Nexus - 0215 - New Times Magazine/pages/0022/image.png)
Page Content (OCR)
These are the facts about vaccines that the medical profes- sion and the drug companies won't tell you. In 1960, at the age of 6 years, I was given my first tetanus injection after piercing my leg on a piece of rusted barbed wire. The previous year, the Medical Journal of Australia contained a number of letters on Tetanus Prophylaxis written by concerned doctors. Some excerpts from these letters follow: “Press (1948) also quotes a number of references which testify to what is generally known—that practically any study of the illness reveals many cases in which tetanus antitoxin failed to prevent tetanus; and this author ay an average of figures quoted in the literature showing that 33.4% of cases which had doviagad tetanus had received prophylactic antiserum (the average in non-military cases was 6.8%). Thus it is seen that antiserum is by no means efficacious in the prevention of tetanus in humans; also, in these cases the patient not only has the risk of contracting tetanus, but has the added risk of the complications of therapy. "The complications of horse serum injections range from minor local reactions through reactions of gradually increasing severity such as generalised urticaria, arthralgia, signs and symptoms of heart, lung and kidney involvement to neurological complications, some of which are of considerable danger to the patient, with cases of radiculitis, brachial plexus neuritis, polyneuritis, Guillain-Barre syndrome, myelitis and cerebral and meningeal reactions (Miller and Stanton, 1954; Woolling and Rushton, 1950). "It would seem that if the figures quoted are correct, then a doctor who gives tetanus antitoxin should rather be sued for exposing the patient to unnecessary risk should seri- ous complications of therapy arise. In fact large sums of money have been paid by insurance companies to patients suffering from the complications of serum therapy (Bennett, 1939). Is it possible that ATS, like typhoid vaccine, has been used for so many years with no real proof of its value?" "| had occasion a few years ago to review a great bulk of literature in the English lan- guage, and some selected German translations on the subject. "No evidence was found by me to suggest that tetanus antiserum had any value as a rophylactic agent against the development of tetanus following accidental trauma to umans. If any persons, or the manufacturers of this dangerous material, have evidence to the contrary, the time is ripe to present that evidence for evaluation. "In the absence of such evidence, tetanus antitoxin should be classed as both danger- ous and useless, and its continued manufacture and prescribing as a Pharmaceutical Benefit for the purpose of prophylaxis against tetanus in humans, a waste of public money." "When presented with a break in the skin, recent or old, superficial or penetratin (including impetigo, otitis media, whitlow, etc.) the risk of tetanus infection is explain to the patient—that he has —— a one-in-250,000 chance of contracting the disease from his existing lesion (11 cases per annum in Victoria—population pt immer aga person contracts one potentially tetanic lesion per year). If tetanus is contracted he would have a 40% to 60% chance of recovery. Now if an ATS injection is given, he has a one-in-50,000 to 200,000 chance of dying of anaphylactic shock. He has a three-in-100 chance of developing moderately severe urticaria. After this explanation, the patient usually has second thoughts about receiving an injection of ATS." Extracted from chapter 3 of the book VACCINATION - THE HIDDEN FACTS by lan Sinclair Available through NEXUS Magazine PO Box 30, Mapleton Qid 4560 Price: $29 (includes postage) NEXUSe21 JUNE - JULY 1993 TETANUS VACCINE Dr W. F. Hunter, Medical Journal of Australia (18/7/1959): Dr K. D. Murray, Medical Journal of Australia (31/10/1959): Dr Taylor, Medical Journal of Australia (18/4/1959):